ABDERA THERAPEUTICS
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeutic and commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030. It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.
ABDERA THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Life Science
Founded:
2021-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.abderatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
604.827.1147
Total Funding:
8 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Founder
Official Site Inspections
http://www.abderatherapeutics.com Semrush global rank: 7.06 M Semrush visits lastest month: 615
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Abdera Therapeutics"
Abdera Therapeutics - Crunchbase Company Profile
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy …See details»
Abdera Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Abdera Therapeutics Inc. of South San Francisco, CA. Get the latest business insights from Dun & …See details»
Abdera Therapeutics Company Profile 2024: Valuation, Funding ...
Abdera Therapeutics’s primary industry is Drug Discovery. Is Abdera Therapeutics a private or public company? Abdera Therapeutics is a Private company. What is Abdera Therapeutics’s …See details»
Abdera Therapeutics
Abdera’s ROVErâ„¢ platform integrates cutting-edge drug discovery and antibody engineering technologies to advance novel radiopharmaceutical-based cancer medicines with tunable PK properties focused on maximizing therapeutic …See details»
Abdera Therapeutics - Leadership Team - The Org
The Leadership Team at Abdera Therapeutics is responsible for defining and executing the company's strategic vision, ensuring alignment with its mission to ... the Leadership Team …See details»
Abdera Therapeutics - Craft
Abdera Therapeutics is a biopharmaceutical company that provides an antibody engineering platform to design and develop precision radiopharmaceuticals for cancer. Its radio-optimized …See details»
Abdera Therapeutics - VentureRadar
" Abdera Therapeutics Inc. is a precision oncology company focused on developing next-generation effective targeted alpha radiation therapies (TATs) for patients with relapsed, …See details»
Abdera Therapeutics - Contacts, Employees, Board Members
Organization. Abdera Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
Abdera Therapeutics - VentureRadar
Similar Companies: Alpha-9 Theranostics Canada Private Founded in 2019, Alpha-9 Theranostics is developing differentiated and highly targeted radiopharmaceuticals with the potential to …See details»
Abdera Therapeutics - Overview, News & Similar companies
Abdera Therapeutics Expands Management Team and Board of Directors MENLO PARK, Calif.--(BUSINESS WIRE)--Abdera Therapeutics Inc., a biopharmaceutical company leveraging its …See details»
Abdera Therapeutics - LinkedIn
Abdera Therapeutics | 12,510 followers on LinkedIn. Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most …See details»
Nuclear medicine startup Abdera lands $142M - Business in …
Apr 20, 2023 Abdera Therapeutics Inc., a Vancouver biopharma startup specializing in the treatment of cancer with radioisotopes, has landed $142 million in Series A and B financing, …See details»
Abdera Therapeutics (Canada) Funding: $148.3M - Medical Startups
Dec 10, 2024 Website: https://abderatherapeutics.com Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and …See details»
adMare Launches Abdera with AbCellera as a Founding Partner
Jan 14, 2021 adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with founding partner, AbCellera …See details»
Startup Abdera raises $110M to fuel radiopharmaceutical research
Apr 20, 2023 Leadership of Abdera Therapeutics Permission granted by Abdera Therapeutics A three-year-old biotechnology startup believes it can solve one of the central challenges in …See details»
Cancer Biotech Abdera Reveals $142M for Better Antibody-Based …
Apr 20, 2023 Abdera Therapeutics emerged from stealth with technology that improves the way antibodies deliver radiopharmaceuticals for cancer. A lead program with preclinical proof-of …See details»
Abdera Therapeutics Debuts With $142 Million in Financing to …
Apr 20, 2023 MENLO PARK, CA and VANCOUVER, British Columbia, April 20, 2023 – Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering …See details»
adMare Launches Abdera with AbCellera as a Founding Partner
Jan 14, 2021 adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with founding partner, AbCellera …See details»